SPS3

SPS3

Neurology A clinical trial–Stroke Prevention of Small Subcortical Strokes
Mentioned in ?
References in periodicals archive ?
Blood-pressure targets in patients with recent lacunar stroke: The SPS3 randomised trial.
SPS3 Investigators, Benavente OR, Hart RG, McClure LA, Szychowski JM, Coffey CS, et al.
The SPS3 study was sponsored by the National Institute of Neurological Disorders and Stroke.
The SPS3 trial was a randomized, multicenter clinical trial conducted in 82 clinical centers inNorth America, Latin America, and Spain.
SPS3 did not include a patient group treated only with clopidogrel because previous, large studies had already compared clopidogrel alone with aspirin alone, and with aspirin plus dipyridamole.